saplin

Compare funds

Axis Midcap vs HSBC Midcap

Both are mid cap funds. Over the last 3 years Axis Midcap returned 16.9% a year and HSBC Midcap 21.8%, against a category median of 16.4%. Axis Midcap costs 0.77% a year and HSBC Midcap 1.08%. On the saplin Score Axis Midcap rates 7.7 (Neutral) and HSBC Midcap 7.7 (Neutral) within their category. 32.2% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

Axis MidcapHSBC MidcapCategory median
saplin Score (0–10)7.7 Neutral7.7 Neutral—
1-year return7.6%16.1%4.9%
3-year return, a year16.9%21.8%16.4%
5-year return, a year12.3%—14.3%
Volatility (standard deviation)16.5%20.6%18.3%
Sharpe ratio0.670.780.62
Beta0.841.030.95
Upside capture9011498
Downside capture759290
Expense ratio (Direct)0.77%1.08%0.94%
Fund size₹34,576 cr₹16,299 cr₹7,096 cr
Number of holdings857574
Top 10 holdings, share of fund26.5%37.1%27.5%
Portfolio P/E45.342.034.1
Lead managerShreyash Devalkar (10 yrs)Cheenu Gupta (3 yrs)—
Launched18 Feb 20119 Aug 2004—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

Axis Midcap and HSBC Midcap have 32.2% of their portfolios in the same stocks (31 holdings in common, portfolios as of 31 Aug 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsAxis MidcapHSBC Midcap
The Federal Bank4.27%3.96%
Apar Industries2.45%3.38%
Lenskart Solutions2.39%4.81%
GE Vernova T&D India2.32%3.20%
FSN E-Commerce Ventures2.04%3.61%
Ather Energy1.96%3.57%
Coforge1.79%1.92%
IPCA Laboratories2.32%1.75%
Bharat Forge1.69%2.79%
Radico Khaitan1.68%2.70%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.